| 摘要 |
This invention relates to new retinoic acid receptor selective retinoid agonists, to pharmaceutical compositions containing such compounds, and to the use of such retinoic acid receptor agonists, particularly retinoic acid receptor gamma (RARgamma) selective agonists, for the treatment of emphysema and related pulmonary diseases.
|
